|
|
| 3rd ESU Masterclass Presents Insightful Updates On Urological Oncology |
| 7/4/2008 2:49:02 PM |
| Insightful updates on onco-urological issues were the focus of the 3rd ESU masterclass, which started in Barcelona on Friday 27 June. There were 150 participants who listened to a faculty of 12 internationally renowned experts in urological cancers. The European Board of Urology (EBU) organised a written examination following the masterclass which is accredited within the EU-ACME programme. >> More |
|
| Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer |
| 7/4/2008 2:49:02 PM |
| Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine. >> More |
|
| Advanced Thyroid Cancer Investigational Drug Shows Promise |
| 7/4/2008 2:49:02 PM |
| A study by an international team of researchers found that an experimental drug that stops blood vessels that feed tumors from forming was able, in a small number of patients, to slow down the progression of advanced thyroid cancer that has spread to other sites. >> More |
|
|
|
|
|
| Targeted Therapies To Lead New Wave Of Breast Cancer Treatments |
| 7/4/2008 2:49:02 PM |
| Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from Frost & Sullivan, U.S. >> More |
|
| Potential New Ways To Treat Metastatic Cancer Following Discovery Of Gene Mechanism |
| 7/4/2008 2:49:02 PM |
| Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease. >> More |
|
|
|
|
|